INDUSTRY RESEARCH

Market intelligence across pharma, MedTech, and digital health.

3,460+ published studies covering therapeutics, diagnostics, devices, and healthcare services — sized bottom-up and top-down, validated by our dedicated Healthcare & Medical Devices research team, and delivered with country-level detail.

3,460+ Published studies
9 Sub-domains tracked
100+ Countries covered
Weekly New titles added
Our expertise in this vertical

The Healthcare & Medical Devices Research Team

This vertical is covered by a dedicated research group inside Fundamental Business Insights that tracks the global healthcare and medical technology industry full-time. Our analysts follow clinical adoption trends, regulatory developments, reimbursement policy, healthcare infrastructure investment, and evolving patient-care requirements as they happen — not just at the point a report is commissioned.

Every estimate in this vertical is built from primary conversations with healthcare stakeholders and cross-checked against company financial disclosures, regulatory publications, clinical literature, and government health databases, then reconciled through both bottom-up and top-down modeling before an internal quality review.

HC Reports in this section are prepared and reviewed by the Healthcare & Medical Devices research team.

Who we interview

Clinical KOLs, regulatory affairs heads, hospital procurement leads, and MedTech product & commercial teams.

Regulatory fluency

Analysts track FDA, EMA, and regional approval pathways so device and drug forecasts reflect real timelines.

Reimbursement modeling

Forecasts factor in payer policy and reimbursement shifts, not just clinical or technology adoption curves.

Coverage within this vertical

Sub-domains we track

Healthcare & Medical Devices reports on this site span the following sub-domains. Reports aren't filed under these as separate sub-categories yet — search or browse the full list below to find a specific market.

01

Pharmaceuticals

Small-molecule and branded/generic drug markets across therapeutic areas and dosage forms.

02

Biotechnology & Advanced Therapies

Cell and gene therapies, biologics, and next-generation biotech platforms.

03

Medical Devices

Diagnostic, surgical, monitoring, and implantable device categories across care settings.

04

Medical Diagnostics

In-vitro diagnostics, imaging, and point-of-care testing markets.

05

Analytical & Laboratory Technologies

Lab instrumentation, reagents, and analytical platforms used in research and clinical settings.

06

Healthcare IT & Digital Health

EHR platforms, telehealth, remote monitoring, and clinical software markets.

07

Clinical & Healthcare Services

Hospital operations, outpatient care, and healthcare service delivery models.

08

Veterinary Healthcare

Animal health diagnostics, pharmaceuticals, and veterinary device markets.

09

Life Science Research Tools

Instruments, reagents, and platforms supporting pharmaceutical and academic research.

These sub-domains describe the breadth of coverage in this vertical — the report list below isn't filterable by sub-domain. Use search or contact us if you're after a specific market.
Research intelligence

Secondary sources behind this vertical

Alongside primary interviews, every Healthcare & Medical Devices estimate is checked against these authoritative public and regulatory sources.

Secondary source Official website
World Health Organization (WHO) who.int ↗
U.S. Food & Drug Administration (FDA) fda.gov ↗
European Medicines Agency (EMA) ema.europa.eu ↗
Centers for Disease Control and Prevention (CDC) cdc.gov ↗
National Institutes of Health (NIH) nih.gov ↗
National Center for Biotechnology Information (NCBI) ncbi.nlm.nih.gov ↗
PubMed pubmed.ncbi.nlm.nih.gov ↗
ClinicalTrials.gov clinicaltrials.gov ↗
International Organization for Standardization (ISO) iso.org ↗
ASTM International astm.org ↗
Advanced Medical Technology Association (AdvaMed) advamed.org ↗
Medical Device Innovation Consortium (MDIC) mdic.org ↗
Biotechnology Innovation Organization (BIO) bio.org ↗
Int'l Federation of Pharmaceutical Manufacturers & Associations (IFPMA) ifpma.org ↗
U.S. Pharmacopeia (USP) usp.org ↗
European Directorate for the Quality of Medicines & HealthCare (EDQM) edqm.eu ↗
World Organisation for Animal Health (WOAH) woah.org ↗
American Hospital Association (AHA) aha.org ↗
OECD Health oecd.org/health ↗
World Bank Data data.worldbank.org ↗
Showing 91 – 100 of 4,607 Industry Research reports
Industry Research Oct 2026

Healthcare Augmented and Virtual Reality Market Size & Forecasts 2026-2035, By Segments (Technology, Component, Application, End-User), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Johnson & Johnson, Medtronic, Philips, GE Healthcare, Siemens Healthineers)

Healthcare Augmented and Virtual Reality Market size is projected to grow steadily from USD 3.67 billion in 2025 to USD 19.87 billion by 2035, demonstrating a CAGR exceeding 18.4%...

Industry Research Oct 2026

Point of Care Glucose Testing Market Size & Forecasts 2026-2035, By Segments (Product, End-User), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Abbott, Roche, Siemens Healthineers, Danaher, Becton Dickinson)

Point of Care Glucose Testing Market size is expected to advance from USD 4.59 billion in 2025 to USD 7.77 billion by 2035, registering a CAGR of more than 5.4% across 2026-2035. B...

Industry Research Oct 2026

Bone Growth Stimulation Devices Market Size & Forecasts 2026-2035, By Segments (Product, Application, End-User), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Zimmer Biomet, Stryker, Orthofix, Bioventus, Smith & Nephew)

Bone Growth Stimulation Devices Market size is anticipated to rise from USD 2.5 billion in 2025 to USD 6.85 billion by 2035, reflecting a CAGR surpassing 10.6% over the forecast ho...

Industry Research Oct 2026

Companion Animal Healthcare Market Size & Growth Forecast 2027–2036, By Segments (Product, Animal, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Companion Animal Healthcare Market size is forecasted to reach USD 247.35 billion by 2035, rising from USD 114.57 billion in 2025, at a CAGR of more than 8% between 2026 and 2035....

Industry Research Oct 2026

Adeno Associated Virus Vectors Manufacturing Market Size & Growth Forecast 2027–2036, By Segments (Method, Application, Therapeutic Area), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Adeno Associated Virus Vectors Manufacturing Market size is forecasted to reach USD 9.79 billion by 2035, rising from USD 1.34 billion in 2025, at a CAGR of more than 22% between 2...

Industry Research Oct 2026

Drug Discovery Outsourcing Services Market Size & Growth Forecast 2027–2036, By Segments (Drug Type, Disease Model, Service Type, Therapeutic Area), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Drug Discovery Outsourcing Services Market size is projected to grow steadily from USD 5.47 billion in 2025 to USD 12.14 billion by 2035, demonstrating a CAGR exceeding 8.3% throug...

Industry Research Oct 2026

Uterine Fibroid Treatment Devices Market Size & Share, By Technology (Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques), Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, Non-invasive Treatment) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

The global uterine fibroid treatment devices market size is predicted to reach USD 27.63 billion by 2034, up from USD 11.46 billion in 2024, reflecting a CAGR of over 9.2% during t...

Industry Research Oct 2026

Dermatology Drugs Market Size & Growth Forecast 2027–2036, By Segments (Route of Administration, Indication Type, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Dermatology Drugs Market size is estimated to increase from USD 35.7 billion in 2025 to USD 96.89 billion by 2035, supported by a CAGR exceeding 10.5% during 2026-2035. In 2026, re...

Industry Research Oct 2026

Oncology Molecular Diagnostic Market Size & Share, By Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Other Cancer), Technology (PCR, In Situ Hybridization, INAAT, Chips and Microarrays, Mass Spectrometry, Sequencing, TMA, Others), Product (Instruments, Reagents, Others ) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

The global oncology molecular diagnostic market size is set to grow from USD 2.25 billion in 2024 to USD 6.33 billion by 2034, reflecting a CAGR of more than 10.9% between 2025 and...

Industry Research Oct 2026

Pharmaceutical Contract Sales Outsourcing (CSO) Market Size & Share, By Service (Personal Promotion, Non-personal Promotion, Others), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, Others) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

The global pharmaceutical contract sales outsourcing (cso) market size is projected to rise from USD 10.82 billion in 2024 to USD 24.69 billion by 2034, representing a CAGR above 8...

Need an Industry Research study we haven't published yet?

Our Healthcare team scopes custom studies using the same interview network and validation framework — typically delivered in 2–3 weeks.